Basic gene annotations are collected from Uniprot and displayed with links to original sources. A quick link to explore the genomic context with Uniprot Browser is available.
BPTF - bromodomain PHD finger transcription factor
Function
Regulatory subunit of the ATP-dependent NURF-1 and NURF-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:14609955, PubMed:28801535). The NURF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the NURF-5 ISWI chromatin remodeling complex (PubMed:28801535). Within the NURF-1 ISWI chromatin-remodeling complex, binds to the promoters of En1 and En2 to positively regulate their expression and promote brain development (PubMed:14609955). Histone-binding protein which binds to H3 tails trimethylated on 'Lys-4' (H3K4me3), which mark transcription start sites of active genes (PubMed:16728976, PubMed:16728978). Binds to histone H3 tails dimethylated on 'Lys-4' (H3K4Me2) to a lesser extent (PubMed:16728976, PubMed:16728978, PubMed:18042461). May also regulate transcription through direct binding to DNA or transcription factors (PubMed:10575013).
Uniprot Browser| Entrez ID | EnsEMBL ID | Preferred Name | Uniprot ID |
|---|---|---|---|
| 2186 | ENSG00000171634 | BPTF | Q12830 |
Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow, a mutation may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulonthat contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows with ENSG00000171634 as Regulator
| ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
|---|---|---|---|---|---|---|---|---|
| CMF-02097 | ABCA4 | up-regulates | BPTF | activates | R-2864 | 21 | 4 | Drugs (2) |
| CMF-03004 | SPEF2 | up-regulates | BPTF | represses | R-2879 | 21 | 3 | Drugs (2) |
| CMF-08425 | COL17A1 | up-regulates | BPTF | activates | R-2861 | 21 | 1 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)IMSIDOLIMAB, OLECLUMAB, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB |
| CMF-12486 | LAMB3 | up-regulates | BPTF | activates | R-2861 | 21 | 2 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)IMSIDOLIMAB, OLECLUMAB, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB |
| CMF-12755 | RAG2 | up-regulates | BPTF | activates | R-2861 | 21 | 1 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)IMSIDOLIMAB, OLECLUMAB, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB |
| CMF-13154 | SLC26A8 | up-regulates | BPTF | activates | R-2861 | 21 | 5 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)IMSIDOLIMAB, OLECLUMAB, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB |
| CMF-15009 | TG | up-regulates | BPTF | represses | R-2879 | 21 | 4 | Drugs (2) |
| CMF-15262 | HCN1 | up-regulates | BPTF | activates | R-2864 | 21 | 4 | Drugs (2) |
| CMF-15264 | HCN1 | up-regulates | BPTF | activates | R-2861 | 21 | 4 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)IMSIDOLIMAB, OLECLUMAB, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB |
| CMF-16905 | TIE1 | up-regulates | BPTF | activates | R-2861 | 21 | 3 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)IMSIDOLIMAB, OLECLUMAB, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB |
| CMF-18198 | CDH19 | up-regulates | BPTF | activates | R-2861 | 21 | 6 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)IMSIDOLIMAB, OLECLUMAB, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB |
| CMF-19114 | LRP1B | up-regulates | BPTF | activates | R-2861 | 21 | 3 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)IMSIDOLIMAB, OLECLUMAB, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB |
| CMF-21752 | COL1A2 | up-regulates | BPTF | activates | R-2861 | 21 | 6 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)IMSIDOLIMAB, OLECLUMAB, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB |
| CMF-22196 | PODXL | up-regulates | BPTF | represses | R-2879 | 21 | 1 | Drugs (2) |
| CMF-22411 | IDH1 | up-regulates | BPTF | represses | R-2879 | 21 | 10 | Drugs (2) |
| CMF-22413 | IDH1 | up-regulates | BPTF | represses | R-2863 | 21 | 10 | Drugs (8) Regulator Drugs (0)Regulon Drugs (8)ATN-161, CINTREDEKIN BESUDOTOX, NATALIZUMAB, FIRATEGRAST, EMRICASAN, VOLOCIXIMAB, PEGINTERFERON LAMBDA-1A, ABITUZUMAB |
| CMF-22414 | IDH1 | up-regulates | BPTF | activates | R-2874 | 21 | 10 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-23044 | AOX1 | up-regulates | BPTF | represses | R-2879 | 21 | 2 | Drugs (2) |
| CMF-23686 | TP53 | up-regulates | BPTF | represses | R-2879 | 21 | 11 | Drugs (2) |
| CMF-23690 | TP53 | up-regulates | BPTF | represses | R-2863 | 21 | 11 | Drugs (8) Regulator Drugs (0)Regulon Drugs (8)ATN-161, CINTREDEKIN BESUDOTOX, NATALIZUMAB, FIRATEGRAST, EMRICASAN, VOLOCIXIMAB, PEGINTERFERON LAMBDA-1A, ABITUZUMAB |
| CMF-29291 | C12orf51 | up-regulates | BPTF | activates | R-2864 | 21 | 3 | Drugs (2) |
| CMF-29613 | ESRRB | down-regulates | BPTF | activates | R-2864 | 21 | 9 | Drugs (2) |
| CMF-29616 | ESRRB | down-regulates | BPTF | activates | R-2861 | 21 | 9 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)IMSIDOLIMAB, OLECLUMAB, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB |